EVIDENCE FOR MULTIPLE BINDING SITES FOR SEVERAL SPECIES OF HU IFN-ALPHA
几个 HU IFN-α 物种的多个结合位点的证据
基本信息
- 批准号:3804735
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The antiproliferative and competitive binding activities of several
purified species of Hu lymphoblastoid Interferon-alpha were compared to
that of recombinant Interferon-alpha 2b on Daudi and AU937 cells. We
found that the antiproliferative activity of the interferon species on
each cell line has a broad range and that Daudi cells were more sensitive
than AU937 cells. The 50% inhibition of cell growth ranged from .003
ng/ml to greater than 10 ng/ml on Daudi cells and 1.2 ng/ml to >100 ng/ml
on AU937 cells. Scatchard analyses demonstrated that the IFN-alpha 2b
binding site number is greater on Daudi cells (12,700 binding sites/cell)
than AU937 cells (3,300 binding sites/cell); however, their receptor
affinities were similar. Interestingly, there appears to be three species
(n,o,p) which exhibit the highest antiproliferative activities on both
cell lines but do not compete for the Interferon-alpha-2b binding site.
These data suggest that there may be more than one receptor or multiple
receptor components involved in the biological actions of these molecules.
In order to further study different receptors among species O IFN-alpha2b
and other species, we have radiolabeled species O and performed
competitive binding experiments. We also performed cross-linking to
studies with IFN-alpha2b and species O to compare the molecular properties
of the binding sites.
几种化合物的抗增殖和竞争性结合活性
将纯化的Hu类淋巴母细胞干扰素-α与
重组干扰素-α 2b对Daudi和AU 937细胞的作用。 我们
发现干扰素类的抗增殖活性对
每种细胞系都有广泛的范围,Daudi细胞更敏感,
AU 937细胞 细胞生长的50%抑制范围为0.003
在Daudi细胞上为1.2ng/ml至>100 ng/ml,
AU 937细胞 Scatchard分析表明,IFN-α 2b
Daudi细胞上的结合位点数量更多(12,700个结合位点/细胞)
比AU 937细胞(3,300个结合位点/细胞);然而,它们的受体
亲和力相似。 有趣的是,似乎有三种
(n,o,p),其在两种细胞上均表现出最高的抗增殖活性。
细胞系,但不竞争干扰素-α-2b结合位点。
这些数据表明,可能有一个以上的受体或多个
参与这些分子的生物学作用的受体成分。
为了进一步研究IFN-α 2b在物种间的不同受体,
和其他物种,我们放射性标记了物种O,
竞争性结合实验 我们还进行了交联,
使用IFN-α 2b和O类进行的比较分子特性的研究
的结合位点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R Q HU其他文献
R Q HU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R Q HU', 18)}}的其他基金
RELATION OF STRUCTURE AND FUNCTION OF HU IFN-GAMMA BY SITE-DIRECTED MUTAGENESIS
通过定点诱变研究HU IFN-γ的结构与功能关系
- 批准号:
3804757 - 财政年份:
- 资助金额:
-- - 项目类别:
CDNA CLONING AND EXPRESSION OF HUMAN IFN-ALPHA SPECIES O
人 IFN-α 物种 O 的 CDNA 克隆和表达
- 批准号:
3804756 - 财政年份:
- 资助金额:
-- - 项目类别:
CDNA CLONING AND EXPRESSION OF HUMAN IFN-ALPHA SPECIES O AND F
人干扰素α物种O和F的CDNA克隆和表达
- 批准号:
3792470 - 财政年份:
- 资助金额:
-- - 项目类别:
EVIDENCE FOR MULTIPLE BINDING SITES FOR SEVERAL SPECIES OF HU IFN ALPHA
几种 HU IFN α 的多个结合位点的证据
- 批准号:
3811196 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES ON PROPERTIES OF LYMPHOBLASTOID INTERFERON ALPHA COMPONENT O
淋巴母细胞干扰素α组分O的性质研究
- 批准号:
3792458 - 财政年份:
- 资助金额:
-- - 项目类别:
ENZYMATIC RESYNTHESIS OF HUMAN IFN-GAMMA N-TERMINAL PEPTIDE
人干扰素-γ N 端肽的酶法再合成
- 批准号:
3811194 - 财政年份:
- 资助金额:
-- - 项目类别:
RELATIONSHIP OF STRUCTURE & FUNCTION OF HU IFN-GAMMA BY SITE-DIRECTED MUTAGENESIS
结构关系
- 批准号:
3811195 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
DNA glycosylases involved in interstrand crosslink repair and antibiotic self-resistance
DNA糖基化酶参与链间交联修复和抗生素自身抗性
- 批准号:
2341288 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
CAREER: Uncovering Mechanisms of DNA-protein Crosslink Repair
职业:揭示 DNA-蛋白质交联修复机制
- 批准号:
2335208 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
Investigating the molecular mechanism of SNM1A nuclease in DNA interstrand crosslink repair
研究SNM1A核酸酶在DNA链间交联修复中的分子机制
- 批准号:
548157-2020 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Postgraduate Scholarships - Doctoral
CAREER: Uncovering Mechanisms of DNA-protein Crosslink Repair
职业:揭示 DNA-蛋白质交联修复机制
- 批准号:
2146384 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Continuing Grant
A molecular and structural approach to understanding interstrand crosslink incision by the Fanconi anaemia DNA repair pathway
通过分子和结构方法了解 Fanconi 贫血 DNA 修复途径的链间交联切口
- 批准号:
MR/X000192/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
SPRTN 蛋白酶的调节和 SPRTN 介导的 DNA-蛋白质交联修复
- 批准号:
10446610 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
SPRTN 蛋白酶的调节和 SPRTN 介导的 DNA-蛋白质交联修复
- 批准号:
10641893 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10438886 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10296087 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Investigating the molecular mechanism of SNM1A nuclease in DNA interstrand crosslink repair
研究SNM1A核酸酶在DNA链间交联修复中的分子机制
- 批准号:
548157-2020 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Postgraduate Scholarships - Doctoral